Ignite Creation Date:
2024-05-06 @ 7:47 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06132191
Status:
AVAILABLE
Last Update Posted:
2023-11-15
First Post:
2023-11-09
Brief Title:
Expanded Access Use of Cemiplimab in Patients With Solid Tumors
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Conditions & Keywords Data
Conditions:
Keywords: